Yew Bio-Pharm Group Inc YEWB Stock Analysis
- EXPM
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.00
Last close · Previous close $0.00
Closing prices across missing sessions after May 12 match a possible 5-for-1 stock split. Until Tiingo publishes the missing split-adjusted prices, the Nov 8 price isn’t compared with earlier prices.
- Market cap
- $10.34KAs of Nov 8, 2023
- Dividend yield
- NoneLast 12 months
Price chart
$0.00Past month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.00Nov 7
- Volume0.00Nov 8 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume25.00Last 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Returns are paused: earlier prices don’t yet reflect the 5-for-1 split that the Nov 8 close suggests. See the note under the price.
All-time high
$0.44
Closing high on .
Split-adjusted daily closes since Jan 13, 2016.
Stock splits
YEWB hasn’t split since its price history begins in 2016.
The Nov 8 close suggests a stock split (5-for-1) that the price history doesn’t include yet. See the note under the price.
Valuation
Price-based measures are paused: per-share results don’t yet reflect the 5-for-1 split that the Nov 8 close suggests. See the note under the price. Market cap and enterprise value are as of Nov 8, 2023. Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
Not available
12-month figures aren’t available until four quarters are reported.
Other valuation measures
- Price-to-bookPausedSee the split note
- $9.37MAs of Nov 8, 2023
What it would cost to buy the whole business: the market cap on Nov 8, 2023, plus debt, minus cash and short-term investments from the Mar 31, 2021 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own YEWB DCF in Excel. Value Yew Bio-Pharm Group with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q1 FY21, the quarter ended Mar 31, 2021, and balance-sheet figures are as of Mar 31, 2021. 12-month figures aren’t available until four quarters are reported.
Revenue and net income
12-month figures aren’t available until four quarters are reported.
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY20 (Dec 31, 2020) | $5.36M | −$420.07K | Paused See the note under the price. |
| Q1 FY21 (Mar 31, 2021) | $8.74M | $2.91M | Paused See the note under the price. |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY20 (Dec 31, 2020) | $27.31M | $1.46M | Paused See the note under the price. |
Margins
- Gross
- Operating
- Net
The lines show each quarter. What margins tell you
Cash flow
12-month figures aren’t available until four quarters are reported.
Shareholder returns
12-month figures aren’t available until four quarters are reported.
Balance sheet
- $127.33KAs of Mar 31, 2021
Cash plus short- and long-term marketable securities on the Mar 31, 2021 balance sheet.
- Total debt$9.49MAs of Mar 31, 2021
- Net debt$9.36MAs of Mar 31, 2021
- Book value per sharePausedAs of Mar 31, 2021
See the note under the price. - 1.28As of Mar 31, 2021
Current assets divided by current liabilities on the Mar 31, 2021 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.20As of Mar 31, 2021
Total debt divided by shareholders’ equity on the Mar 31, 2021 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
12-month figures aren’t available until four quarters are reported.
About Yew Bio-Pharm Group Inc
Yew Bio-Pharm Group, Inc., through its subsidiaries, grows and sells yew trees in the Peoples Republic of China. The company is involved in the cultivation and sale of yew seedlings and trees to state-owned enterprises and private businesses for reforestation in Heilongjiang and Jilin provinces; and sale of potted yew trees to retail customers. It also produces and sells yew raw materials, including branches and leaves of yew trees for medicinal application in the pharmaceutical industry; and furniture and handicrafts that are made from yew timber. The company sells its products through a network of distributors. Yew Bio-Pharm Group, Inc. was incorporated in 2007 and is based in Las Vegas, Nevada.
- Sector
- Consumer Defensive
- Industry
- Farm Products
- Headquarters
- California, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- EXPM
- Asset type
- Common stock
- Price history since
YEWB news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
YEWB stock FAQ
What is YEWB stock’s price today?
Yew Bio-Pharm Group (YEWB) traded at $0.00 at the close on . That price suggests a stock split (5-for-1) that earlier prices on this page don’t reflect yet.
What is Yew Bio-Pharm Group’s market cap?
Yew Bio-Pharm Group’s market capitalization was about $10.3 thousand on , according to Tiingo’s daily data (how market cap works).
Does YEWB pay a dividend?
Yew Bio-Pharm Group hasn’t paid a dividend in the last twelve months.
What is YEWB’s all-time high?
YEWB’s highest closing price was $0.44 on , adjusted for stock splits.
Has YEWB stock ever split?
No. YEWB hasn’t split since its price history begins in 2016. The Nov 8 close suggests a stock split (5-for-1) that the price history doesn’t include yet.
What sector and industry is Yew Bio-Pharm Group in?
Yew Bio-Pharm Group is in the Consumer Defensive sector and the Farm Products industry, and is headquartered in California, USA.
What exchange does YEWB trade on?
Yew Bio-Pharm Group trades on the EXPM under the ticker symbol YEWB. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.